PDF(Pubmed)
Abstract：
Timely diagnosis of multiple sclerosis (MS) is a challenge due to factors such as prompt identification of symptoms and consequent delays in hospital visits and treatment initiation. In part to address this challenge, an expert scientific advisory panel of clinical nurse practitioners (CNPs) from different European nations was convened by Viatris on October 25, 2022, in Amsterdam, the Netherlands. This meeting was an interactive discussion to understand the role of clinical nurse practitioners in MS management. The objectives were to (1) understand the current delays in MS diagnosis from the perspective of expert CNPs; (2) determine the role of the CNP in MS management; and (3) identify the opportunities to improve accessibility, foster collaboration among stakeholders, and promote initiatives to educate people with MS. The recommendations of the panel underline the multidimensional role of CNPs in the management of MS at all stages. Health care stakeholders need to work together to achieve better access to treatment regimens and facilitate outcomes in the management of MS through shared decision-making and follow-ups. Further exploration of the role of CNPs in the management of MS, as well as recommendations for early diagnosis, will help both general practitioners and specialists better manage MS care.
摘要：
由于诸如迅速识别症状以及随之而来的住院就诊和治疗开始的延迟等因素，及时诊断多发性硬化症（MS）是一项挑战。为了应对这一挑战，Viatris于2022年10月25日在阿姆斯特丹召集了来自不同欧洲国家的临床护士从业人员（CNPs）专家科学咨询小组，荷兰。这次会议是一个互动讨论，以了解临床护士从业人员在MS管理中的作用。目标是（1）从专家CNP的角度了解MS诊断的当前延迟；（2）确定CNP在MS管理中的作用；（3）确定改善可访问性的机会，促进利益相关者之间的合作，并促进对女士进行教育的举措。小组的建议强调了CNP在管理MS各个阶段的多维作用。医疗保健利益相关者需要共同努力，通过共同的决策和后续行动，更好地获得治疗方案，并促进MS管理的成果。进一步探讨CNPs在MS管理中的作用，以及早期诊断的建议，将帮助全科医生和专家更好地管理MS护理。
